Xueyan Peng

1.9k total citations
24 papers, 1.2k citations indexed

About

Xueyan Peng is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Xueyan Peng has authored 24 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Immunology. Recurrent topics in Xueyan Peng's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Studies on Chitinases and Chitosanases (4 papers) and Protist diversity and phylogeny (3 papers). Xueyan Peng is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Studies on Chitinases and Chitosanases (4 papers) and Protist diversity and phylogeny (3 papers). Xueyan Peng collaborates with scholars based in United States, China and Russia. Xueyan Peng's co-authors include Erica L. Herzog, Mridu Gulati, Jack A. Elias, Silva Markovic‐Plese, Huanxing Sun, Xin Zhang, Vinod S. Ramgolam, Jianping Jin, Robert Homer and Ruth R. Montgomery and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

Xueyan Peng

24 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xueyan Peng United States 15 450 438 375 176 163 24 1.2k
Hirokazu Yasuno Japan 21 372 0.8× 223 0.5× 119 0.3× 147 0.8× 203 1.2× 89 1.4k
Alexandros Onoufriadis United Kingdom 16 375 0.8× 166 0.4× 357 1.0× 95 0.5× 109 0.7× 44 1.1k
Liyang Dong China 19 674 1.5× 137 0.3× 371 1.0× 45 0.3× 149 0.9× 54 1.3k
Anna P. Lam United States 13 526 1.2× 428 1.0× 170 0.5× 171 1.0× 71 0.4× 19 1.0k
Jorma A. Määttä Finland 23 786 1.7× 168 0.4× 500 1.3× 88 0.5× 672 4.1× 56 1.8k
Stacy Porvasnik United States 21 505 1.1× 141 0.3× 135 0.4× 78 0.4× 218 1.3× 47 1.3k
Christopher Siatskas Australia 20 482 1.1× 102 0.2× 343 0.9× 113 0.6× 166 1.0× 39 1.3k
Eko Raharjo Canada 13 420 0.9× 120 0.3× 582 1.6× 34 0.2× 126 0.8× 15 1.4k
Andrés Rojas United States 16 508 1.1× 104 0.2× 451 1.2× 128 0.7× 310 1.9× 24 1.3k
Parth Shah United States 10 244 0.5× 114 0.3× 673 1.8× 65 0.4× 110 0.7× 58 1.1k

Countries citing papers authored by Xueyan Peng

Since Specialization
Citations

This map shows the geographic impact of Xueyan Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueyan Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueyan Peng more than expected).

Fields of papers citing papers by Xueyan Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xueyan Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueyan Peng. The network helps show where Xueyan Peng may publish in the future.

Co-authorship network of co-authors of Xueyan Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Xueyan Peng. A scholar is included among the top collaborators of Xueyan Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueyan Peng. Xueyan Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peng, Xueyan, Shu Li, Mingxin Li, et al.. (2024). Metagenomic Insight into the Associated Microbiome in Plasmodia of Myxomycetes. Microorganisms. 12(12). 2540–2540. 2 indexed citations
2.
Kim, Jin‐Hwan, Xueyan Peng, Yuping Cai, et al.. (2023). Toll-like Receptor-9 Activation Promotes Persistent Inflammation in the Lung During Influenza Infection. A5608–A5608. 1 indexed citations
3.
Li, Shu, Qi Bao, Xueyan Peng, et al.. (2023). Genome size and GC content of myxomycetes. European Journal of Protistology. 90. 125991–125991. 1 indexed citations
4.
Yi, Yong, et al.. (2023). R3-MYB proteins OsTCL1 and OsTCL2 modulate seed germination via dual pathways in rice. The Crop Journal. 11(6). 1752–1761. 4 indexed citations
5.
Li, Shu, Qi Bao, Wan Wang, et al.. (2022). Diversity of bacterial communities in the plasmodia of myxomycetes. BMC Microbiology. 22(1). 314–314. 5 indexed citations
6.
Gao, Ruijuan, Xueyan Peng, Huanxing Sun, et al.. (2021). Macrophage-derived netrin-1 drives adrenergic nerve–associated lung fibrosis. Journal of Clinical Investigation. 131(1). 43 indexed citations
7.
Sava, Paul, Anand Ramanathan, Xueyan Peng, et al.. (2017). Human pericytes adopt myofibroblast properties in the microenvironment of the IPF lung. JCI Insight. 2(24). 101 indexed citations
8.
Ma, Bing, Erica L. Herzog, Chun Geun Lee, et al.. (2014). Role of Chitinase 3–like-1 and Semaphorin 7a in Pulmonary Melanoma Metastasis. Cancer Research. 75(3). 487–496. 67 indexed citations
9.
Peng, Xueyan, Meagan W. Moore, Hong Peng, et al.. (2014). CD4+CD25+FoxP3+ Regulatory Tregs inhibit fibrocyte recruitment and fibrosis via suppression of FGF-9 production in the TGF-β1 exposed murine lung. Frontiers in Pharmacology. 5. 80–80. 37 indexed citations
10.
Zhou, Yang, Hong Peng, Huanxing Sun, et al.. (2014). Chitinase 3–Like 1 Suppresses Injury and Promotes Fibroproliferative Responses in Mammalian Lung Fibrosis. Science Translational Medicine. 6(240). 240ra76–240ra76. 149 indexed citations
11.
Sun, Huanxing, Elizabeth A. Calle, Xiaosong Chen, et al.. (2013). Fibroblast engraftment in the decellularized mouse lung occurs via a β1-integrin-dependent, FAK-dependent pathway that is mediated by ERK and opposed by AKT. American Journal of Physiology-Lung Cellular and Molecular Physiology. 306(6). L463–L475. 29 indexed citations
12.
Reilkoff, Ronald A., Hong Peng, Lynne A. Murray, et al.. (2012). Semaphorin 7a+ Regulatory T Cells Are Associated with Progressive Idiopathic Pulmonary Fibrosis and Are Implicated in Transforming Growth Factor-β1–induced Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 187(2). 180–188. 97 indexed citations
13.
Lee, Chun Geun, Erica L. Herzog, Farida Ahangari, et al.. (2012). Chitinase 1 Is a Biomarker for and Therapeutic Target in Scleroderma-Associated Interstitial Lung Disease That Augments TGF-β1 Signaling. The Journal of Immunology. 189(5). 2635–2644. 73 indexed citations
14.
Gan, Ye, Ronald A. Reilkoff, Xueyan Peng, et al.. (2011). Role of semaphorin 7a signaling in transforming growth factor β1–induced lung fibrosis and scleroderma‐related interstitial lung disease. Arthritis & Rheumatism. 63(8). 2484–2494. 71 indexed citations
15.
Peng, Xueyan, Susan Mathai, Lynne A. Murray, et al.. (2011). Local apoptosis promotes collagen production by monocyte-derived cells in transforming growth factor β1-induced lung fibrosis. PubMed. 4(1). 12–12. 32 indexed citations
16.
Reilkoff, Ronald A., Thomas Russell, Xueyan Peng, et al.. (2011). Semaphorin 7A Expression On Lymphocytes Promotes Alternative Macrophage Activation In Murine Models Of Lung Fibrosis And Human IPF. A5575–A5575. 1 indexed citations
17.
Mathai, Susan, Mridu Gulati, Xueyan Peng, et al.. (2010). Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype. Laboratory Investigation. 90(6). 812–823. 179 indexed citations
18.
Zhang, Xin, Jianping Jin, Xueyan Peng, Vinod S. Ramgolam, & Silva Markovic‐Plese. (2008). Simvastatin Inhibits IL-17 Secretion by Targeting Multiple IL-17-Regulatory Cytokines and by Inhibiting the Expression of IL-17 Transcription Factor RORC in CD4+ Lymphocytes. The Journal of Immunology. 180(10). 6988–6996. 162 indexed citations
19.
Peng, Xueyan, Jianping Jin, Shailendra Giri, et al.. (2006). Immunomodulatory effects of 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors, potential therapy for relapsing remitting multiple sclerosis. Journal of Neuroimmunology. 178(1-2). 130–139. 31 indexed citations
20.
Fujii, Takuma, Janet L. Brandsma, Xueyan Peng, et al.. (2001). High and Low Levels of Cottontail Rabbit Papillomavirus E2 Protein Generate Opposite Effects on Gene Expression. Journal of Biological Chemistry. 276(2). 867–874. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hirokazu Yasuno Breakdown of academic impact, for papers by Alexandros Onoufriadis Breakdown of academic impact, for papers by Liyang Dong Breakdown of academic impact, for papers by Anna P. Lam Breakdown of academic impact, for papers by Jorma A. Määttä Breakdown of academic impact, for papers by Stacy Porvasnik Breakdown of academic impact, for papers by Christopher Siatskas Breakdown of academic impact, for papers by Eko Raharjo Breakdown of academic impact, for papers by Andrés Rojas Breakdown of academic impact, for papers by Parth Shah
Rankless by CCL
2026